New Publication from Xiang Lab in Cell Mol Immunol

"Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway"


Authors: Wang R, Xu A, Zhang X, Wu J, Freywald A, Xu J, Xiang J.

Cell Mol Immunol. 2016 Jun 6. doi: 10.1038/cmi.2016.23. [Epub ahead of print]   PMID:27264687


 The paper can be accessed here: http://www.ncbi.nlm.nih.gov/pubmed/27264687